AI takes on esophageal cancer: could it spot the disease earlier?
NCT ID NCT07642401
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether an artificial intelligence (AI) model can help doctors better detect, diagnose, and treat esophageal cancer. Researchers will feed de-identified data from 12,000 patients receiving routine care into the AI and compare its recommendations to standard care over three years. The goal is to see if the AI can improve early detection rates and treatment personalization.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could show that AI helps doctors catch esophageal cancer earlier and choose better treatments, potentially improving survival rates.
What could go wrong
This is an observational study, not a controlled trial, so results may not prove cause and effect. The AI model may not work as well in real-world settings or for all patient groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anyang Tumor Hospital
Anyang, Henan, 455000, China
-
Nanyang Central Hospital Medical Ethics Committee
Nanyang, Henan, 473000, China
-
The First Affiliated Hospital of Henan University of Science & Technology
Luoyang, Henan, 471000, China